| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2143546 | Lung Cancer | 2008 | 5 Pages |
Abstract
Cisplatin-gemcitabine combination chemotherapy has modest activity with an acceptable toxicity profile, as first line treatment for patients with malignant mesothelioma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sujith R. Kalmadi, Cathryn Rankin, Michael J. Kraut, Andrew D. Jacobs, Daniel P. Petrylak, David J. Adelstein, Mary Louise Keohan, Robert N. Taub, Ernest C. Borden,